NDC 70518-4571-01 - buprenorphine hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4571
- Requested NDC
- 70518-4571-01
- Package NDCs from labels
- 70518-4571-1, 70518-4571-0, 70518-4571-2, 70518-4571-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-07-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| buprenorphine hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-07-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4571-0 | buprenorphine hydrochloride | 30 in 1 BOX | TABLET | 30 | 1 | |
| 70518-4571-1 | buprenorphine hydrochloride | 1 in 1 POUCH | TABLET | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 121eb51a-befe-47ea-85c6-d77e8c7e5864 | 2025-10-06 | Warnings | XF417D3PSL |
| QUALITY CHOICE Nausea Relief | SODIUM CITRATE DIHYDRATE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | d89e41c1-399a-4157-8d54-bfefe3b1c1cd | 2025-10-01 | Warnings | B22547B95K |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| BUPRENORPHINE | BUPRENORPHINE | Bryant Ranch Prepack | a7da638f-f590-4577-bff9-15a91c6e7917 | 2025-07-29 | Warnings, Adverse reactions | 351264 56W8MW3EN1 |
| Aller-Chord F | ACETALDEHYDE, ACETICUM AC, ARG NIT, CAFFEINUM, CALC SULPH, CITRICUM AC, CORTISONE ACETICUM, ECHINACEA PURP, FOLLICULINUM, FRAGARIA, FUMARICUM AC, GALLICUM AC, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRANGEA, LAC VAC, LECITHIN, LIMULUS, LYCOPERSICUM, LYCOPODIUM, NAT BICARB, NAT MUR, NUX VOM, PARAFFINUM, PHOSPHORICUM AC, SACCHARUM OFF, SILICEA, TARTARICUM AC, TORULA CEREVISIAE. | Energetix Corporation | ff4eb7b2-8272-4bd3-99a9-7e589b30d59a | 2025-07-15 | Warnings | XF417D3PSL |
| Endocrinpath | ALFALFA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CEANOTHUS AMERICANUS, CITRICUM ACIDUM, FUCUS VESICULOSUS, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYDROCOTYLE ASIATICA, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, PANCREAS SUIS, PHYTOLACCA DECANDRA, PITUITARUM POSTERIUM (BOVINE), SARSAPARILLA (SMILAX REGELII), SILICEA, SYZYGIUM JAMBOLANUM, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corporation | 70f84941-b8a1-48f4-9c05-554e554f0049 | 2025-07-11 | Warnings | XF417D3PSL |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | XF417D3PSL |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | B22547B95K |
| Nauzene Chewables Ginger Honey | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | 25c9825d-a4e8-4671-e063-6294a90ab46d | 2025-06-24 | Warnings | B22547B95K |
| buprenorphine hydrochloride | BUPRENORPHINE HYDROCHLORIDE | A-S Medication Solutions | c1398d85-d4bb-4426-8ecf-a50400910d81 | 2025-05-28 | Warnings, Adverse reactions | ANDA090622 351265 56W8MW3EN1 |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Nauzene | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | a60660b2-c5db-45a0-885f-de93e655380d | 2025-04-29 | Warnings | B22547B95K |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Kesin Pharma Corporation | 3140f8fe-0644-7561-e063-6394a90a2c28 | 2025-04-21 | Adverse reactions | XF417D3PSL |
| Bio Co Enzyme Phase | ACONITICUM ACIDUM, CIS-, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ADRENALINUM, , ALPHA-KETOGLUTARICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, ASCORBICUM ACIDUM, BARIUM OXALSUCCINICUM, BETA VULGARIS, CERIUM OXALICUM, CITRICUM ACIDUM, CYSTEINUM, FUMARICUM ACIDUM, HEPAR SULPHURIS CALCAREUM, MAGNESIUM OROTICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM PHOSPHORICUM, NADIDUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PANTOTHENIC ACID, PROTEUS (MORGANI), PULSATILLA (PRATENSIS), PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, | Deseret Biologicals, Inc. | 6edee6eb-0ec9-4d2a-9dc9-dc2a6503a6db | 2025-04-08 | Warnings | XF417D3PSL |
| Buprenorphine HCl | BUPRENORPHINE HCL | Bryant Ranch Prepack | d5a8c41e-413e-4d48-9739-d158e5681dd0 | 2025-03-28 | Warnings, Adverse reactions | 351265 56W8MW3EN1 |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | adc1167e-910e-4d7b-abdc-751d3df0c3dc | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | Clinical Solutions Wholesale, LLC | 9d976ee7-9509-49da-89fd-48d7e712697b | 2025-02-17 | Warnings, Adverse reactions | 351264 56W8MW3EN1 |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Somerset Therapeutics, LLC | 74e40c51-853b-4e7f-b3cb-a27af29e1cbf | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | Clinical Solutions Wholesale, LLC | 023c7816-21b1-4f85-be36-9e32d5935c19 | 2025-02-03 | Warnings, Adverse reactions | 351265 56W8MW3EN1 |
| Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | c9d0e9c8-379f-4895-b272-329efab575c4 | 2025-01-24 | Warnings, Adverse reactions | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.